TY - JOUR
T1 - Assessment and site-specific manipulation of DNA (hydroxy-)methylation during mouse corticogenesis
AU - Noack, Florian
AU - Pataskar, Abhijeet
AU - Schneider, Martin
AU - Buchholz, Frank
AU - Tiwari, Vijay K
AU - Calegari, Federico
PY - 2019/4
Y1 - 2019/4
N2 - Dynamic changes in DNA (hydroxy-)methylation are fundamental for stem cell differentiation. However, the signature of these epigenetic marks in specific cell types during corticogenesis is unknown. Moreover, site-specific manipulation of cytosine modifications is needed to reveal the significance and function of these changes. Here, we report the first assessment of (hydroxy-)methylation in neural stem cells, neurogenic progenitors, and newborn neurons during mammalian corticogenesis. We found that gain in hydroxymethylation and loss in methylation occur sequentially at specific cellular transitions during neurogenic commitment. We also found that these changes predominantly occur within enhancers of neurogenic genes up-regulated during neurogenesis and target of pioneer transcription factors. We further optimized the use of dCas9-Tet1 manipulation of (hydroxy-)methylation, locus-specifically, in vivo, showing the biological relevance of our observations for Dchs1, a regulator of corticogenesis involved in developmental malformations and cognitive impairment. Together, our data reveal the dynamics of cytosine modifications in lineage-related cell types, whereby methylation is reduced and hydroxymethylation gained during the neurogenic lineage concurrently with up-regulation of pioneer transcription factors and activation of enhancers for neurogenic genes.
AB - Dynamic changes in DNA (hydroxy-)methylation are fundamental for stem cell differentiation. However, the signature of these epigenetic marks in specific cell types during corticogenesis is unknown. Moreover, site-specific manipulation of cytosine modifications is needed to reveal the significance and function of these changes. Here, we report the first assessment of (hydroxy-)methylation in neural stem cells, neurogenic progenitors, and newborn neurons during mammalian corticogenesis. We found that gain in hydroxymethylation and loss in methylation occur sequentially at specific cellular transitions during neurogenic commitment. We also found that these changes predominantly occur within enhancers of neurogenic genes up-regulated during neurogenesis and target of pioneer transcription factors. We further optimized the use of dCas9-Tet1 manipulation of (hydroxy-)methylation, locus-specifically, in vivo, showing the biological relevance of our observations for Dchs1, a regulator of corticogenesis involved in developmental malformations and cognitive impairment. Together, our data reveal the dynamics of cytosine modifications in lineage-related cell types, whereby methylation is reduced and hydroxymethylation gained during the neurogenic lineage concurrently with up-regulation of pioneer transcription factors and activation of enhancers for neurogenic genes.
KW - 5-Methylcytosine/analogs & derivatives
KW - Animals
KW - CRISPR-Associated Protein 9/metabolism
KW - Cadherins/metabolism
KW - Cell Differentiation
KW - Cell Lineage/physiology
KW - Cytosine/metabolism
KW - DNA Methylation/genetics
KW - DNA-Binding Proteins/genetics
KW - Embryonic Stem Cells/metabolism
KW - Epigenesis, Genetic/genetics
KW - Female
KW - Gene Expression Regulation, Developmental/genetics
KW - Mice
KW - Mice, Inbred C57BL
KW - Neural Stem Cells/metabolism
KW - Neurogenesis/genetics
KW - Oncogene Proteins, Fusion/metabolism
KW - Pregnancy
KW - Proto-Oncogene Proteins/genetics
KW - Transcription Factors
KW - Transcriptome
U2 - 10.26508/lsa.201900331
DO - 10.26508/lsa.201900331
M3 - Journal article
C2 - 30814272
SN - 2575-1077
VL - 2
JO - Life Science Alliance
JF - Life Science Alliance
IS - 2
M1 - e201900331
ER -